Skip to main content
Clinical Trials/NCT03177564
NCT03177564
Unknown
Not Applicable

A Randomized Controlled Trial to Assess the Feasiblity of a Driving Pressure Limited Ventilation vs.Standard Strategy During Video-assisted Thoracoscopic Lobectomy

The Affiliated Hospital of Xuzhou Medical University1 site in 1 country90 target enrollmentJune 5, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Complication
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Enrollment
90
Locations
1
Primary Endpoint
The incidence of postoperative pulmonary complications
Last Updated
8 years ago

Overview

Brief Summary

This study aims to investigate the feasibility of a driving pressure limited mechanical ventilation strategy compared to a conventional strategy in patients undergoing one-lung ventilation during Video-assisted thoracoscopic lobectomy.

Detailed Description

• More recently, the so-called lung-protective intraoperative ventilation strategies have been advocated to prevent lung injury. Such strategies aim at minimizing lung hyperinflation as well as cycling collapse and reopening of lung units, through the use of low tidal volumes (VTs) and positive end-expiratory pressure (PEEP). However, despite huge improvements in surgical and anesthesia techniques and management. It is surprising that, so far, mortality and pulmonary complication rates were not reduced over time .Recently, several investigations suggest an association between high driving pressure (the difference between the plateau pressure and the level of PEEP) and outcome for patients with acute respiratory distress syndrome. It is uncertain whether a similar association exists for high driving pressure during surgery and the occurrence of postoperative pulmonary complications. In this issue, Ary S Neto and colleagues report an individual patient data meta-analysis further investigating the risk of mechanical ventilation in healthy individuals during general anesthesia .After both a multivariate and mediation analysis, the driving pressure, but not the tidal volume or the positive end-expiratory pressure applied, seemed to be the only parameter that was associated with the development of postoperative pulmonary complications. This randomized controlled trial is aims to prove that driving pressure limited ventilation is superior in preventing postoperative pulmonary complications to existing protective ventilation.

Registry
clinicaltrials.gov
Start Date
June 5, 2017
End Date
June 10, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults greater than or equal to 18 years
  • ARISCAT(Assess Respiratory Risk in Surgical Patients in Catalonia)≥26 points
  • Patients undergoing video-assisted thoracoscopic lobectomy

Exclusion Criteria

  • The American Society of Anesthesiologists (ASA) Physical Status classification greater than or equal to 4
  • Emergency surgery
  • Pulmonary hypertension
  • Forced vital capacity or forced expiratory volume in 1 sec \< 70% of the predicted values
  • Coagulation disorder
  • Pulmonary or extrapulmonary infections
  • History of treatment with steroid in 3 months before surgery
  • History of recurrent pneumothorax
  • History of lung resection surgery
  • History of mechanical ventilation in 2 weeks

Outcomes

Primary Outcomes

The incidence of postoperative pulmonary complications

Time Frame: within the first 3 days after surgery

Patient is regarded to have postoperative pulmonary complication when 4 or more positive variables exists according to Melbourne Group Scale.

Secondary Outcomes

  • Partial pressure of oxygen in arterial blood(15 min after induction, 20 and 60 min after start of one-lung ventilation, 15 min after restart of two-lung ventilation, 1 hour after the end of surgery)
  • respiratory compliance(during surgery)
  • TNF-α(the start of one-lung ventilation, 1 hour of one-lung ventilation and the end of one-lung ventilation)
  • IL-8(the start of one-lung ventilation, 1 hour of one-lung ventilation and the end of one-lung ventilation)
  • ICU mortality(Patients will be followed during the period of hospital stay, an expected average of 28 days)
  • In-hospital mortality(Patients will be followed during the period of hospital stay, an expected average of 28 days)
  • 28-day survival(From day 0 to day 28)

Study Sites (1)

Loading locations...

Similar Trials